Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,736 | -24,339 | -19,839 | -13,718 | -7,656 |
| Depreciation Amortization | 494 | 1,861 | 1,383 | 899 | 417 |
| Accounts receivable | 1,190 | -1,138 | -624 | -2,358 | -38 |
| Accounts payable and accrued liabilities | 1,139 | 2,859 | 3,309 | 5,074 | 1,715 |
| Other Working Capital | -276 | 3,741 | 4,855 | 2,840 | 2,740 |
| Other Operating Activity | -1,793 | 1,821 | -780 | -1,421 | -1,141 |
| Operating Cash Flow | $-3,982 | $-15,195 | $-11,696 | $-8,683 | $-3,964 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 15,000 | 12,000 | 6,000 | 3,000 |
| PPE Investments | -427 | -4,880 | -4,279 | -2,555 | -1,767 |
| Purchase Sale Intangibles | -9 | -127 | -104 | -39 | -33 |
| Other Investing Activity | -9 | -127 | -104 | -39 | -33 |
| Investing Cash Flow | $-436 | $9,993 | $7,618 | $3,406 | $1,201 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 381 | 101 | 24 | N/A | N/A |
| Other Financing Activity | 0 | -84 | -64 | -64 | -35 |
| Financing Cash Flow | $381 | $17 | $-40 | $-64 | $-35 |
| Exchange Rate Effect | -1 | 1 | 1 | 2 | 1 |
| Beginning Cash Position | 27,715 | 32,899 | 32,899 | 32,899 | 32,899 |
| End Cash Position | 23,677 | 27,715 | 28,781 | 27,559 | 30,102 |
| Net Cash Flow | $-4,038 | $-5,184 | $-4,117 | $-5,340 | $-2,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,982 | -15,195 | -11,696 | -8,683 | -3,964 |
| Capital Expenditure | -427 | -4,880 | -4,279 | -2,555 | -1,767 |
| Free Cash Flow | -4,409 | -20,075 | -15,975 | -11,238 | -5,731 |